Evidence map›Paper›PMID 41316170›Full record

Trial reportBMC complementary medicine and therapies2025

Experiences with Qi and changes in post-acute sequelae of COVID-19 (PASC) symptoms with qigong: a qualitative analysis of participants' experiences in a pilot clinical trial.

Monica Joy, Nicole Adams, Michael Yanuck, Michelle L Dossett

Registry-linked trialAbstract readRandomized Controlled Trial
In one paragraph

Trial report in BMC complementary medicine and therapies, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05675995 (Qigong for Post Acute Sequelae of COVID-19 Infection), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05675995 nacompletednot on this map

Qigong for Post Acute Sequelae of COVID-19 Infection

TypeinterventionalSponsorUniversity of California, DavisRan2023 to 2024Enrolled40ConditionsLong COVIDArmsQigong
3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Monica JoyUniversity of California Davis School of Medicine, Sacramento, CA, U.S.A.
Nicole AdamsDepartment of Internal Medicine, University of California Davis, Sacramento, CA, U.S.A.
Michael YanuckSacramento VA Medical Center, Mather, CA, U.S.A.
Michelle L DossettDepartment of Internal Medicine, University of California Davis, Sacramento, CA, U.S.A.. mdossett@health.ucdavis.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCommonly known as "long COVID", post-acute sequelae of COVID-19 (PASC) is a chronic condition with no validated treatment that significantly impacts the quality of life of those affected. Qigong is a Traditional Chinese Medicine (TCM) practice that may serve as a possible therapeutic approach for PASC. This study explored participants' experiences with qi, and changes in PASC symptoms, following participation in a clinical trial of group-based, combined external and internal qigong for individuals with PASC.

methodsA qualitative study of 26 individuals who participated in a pilot feasibility trial of qigong for PASC symptoms was performed. Participants engaged in six weekly, two-hour sessions of external and internal qigong delivered in a group-based format. Upon completion of the intervention, all participants were interviewed using a semi-structured interview guide. The interviews were transcribed, coded and analyzed using a conventional content analysis approach to explore participants' perceptions and understanding of qi, qigong, and the overall impact of the sessions on their well-being and PASC symptoms.

resultsParticipants' understanding and explanations of qi varied. Almost all participants (92%) reported feeling qi during the sessions, and a variety of different sensations associated with perception of qi were described. Approximately three-quarters of participants experienced improvement in one or more PASC symptoms, most commonly fatigue, "brain fog", and sleep quality, and 85% reported improved well-being. Additionally, participants frequently cited the group-based nature of the intervention as a positive aspect of their experience.

conclusionsThe qigong intervention was well-received by participants, with the majority perceiving qi and reporting improvements in PASC-related symptoms and overall well-being. These findings suggest that many individuals may be able to perceive qi and that group-delivered combined external and internal qigong may be a beneficial complementary therapy for managing PASC symptoms. As this is a pilot study with a small sample size and a single qigong teacher, results must be interpreted cautiously. Further research is warranted to evaluate the effects of qigong in this patient population.

trial registrationRegistry: ClinicalTrials.gov. Trial Registration Number: NCT05675995. Date of Registration: January 4, 2023.

Indexed as

COVID-19QigongAdultAgedFemaleHumansMaleMiddle AgedPilot ProjectsPost-Acute COVID-19 SyndromeQualitative ResearchQuality of LifeSARS-CoV-2Biofield therapiesIntegrative medicineLong COVIDPost-Acute COVID-19 syndromeQigongQualitative researchTraditional chinese medicine

Identifiers

PMID41316170
PMCPMC12661764

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.